Trospium Chloride Patent Expiration

Trospium Chloride is Used for treating bladder dysfunction. It was first introduced by Allergan Inc in its drug Sanctura on May 28, 2004. Another drug containing Trospium Chloride is Sanctura Xr. 12 different companies have introduced drugs containing Trospium Chloride.


Trospium Chloride Patents

Given below is the list of patents protecting Trospium Chloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sanctura Xr US7410978 Once daily dosage forms of trospium Feb 01, 2025

(Expired)

Allergan
Sanctura Xr US7759359 Method of treating bladder dysfunction with once-a-day trospium salt formulation Nov 04, 2024

(Expired)

Allergan
Sanctura Xr US7763635 Once daily dosage forms of trospium Nov 04, 2024

(Expired)

Allergan
Sanctura Xr US7781448 Once daily dosage forms of trospium Nov 04, 2024

(Expired)

Allergan
Sanctura Xr US7781449 Trospium chloride treatment method Nov 04, 2024

(Expired)

Allergan



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Trospium Chloride's patents.

Given below is the list recent legal activities going on the following patents of Trospium Chloride.

Activity Date Patent Number
Patent litigations
Expire Patent 01 Oct, 2018 US7781449(Litigated)
Expire Patent 01 Oct, 2018 US7781448(Litigated)
Expire Patent 03 Sep, 2018 US7763635(Litigated)
Expire Patent 27 Aug, 2018 US7759359(Litigated)
Maintenance Fee Reminder Mailed 09 Apr, 2018 US7781449(Litigated)
Maintenance Fee Reminder Mailed 09 Apr, 2018 US7781448(Litigated)
Maintenance Fee Reminder Mailed 12 Mar, 2018 US7763635(Litigated)
Maintenance Fee Reminder Mailed 05 Mar, 2018 US7759359(Litigated)
Expire Patent 09 Sep, 2016 US7410978(Litigated)
Change in Power of Attorney (May Include Associate POA) 27 Apr, 2015 US7759359(Litigated)


Trospium Chloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Trospium Chloride Generic API Manufacturers

Several generic applications have been filed for Trospium Chloride. The first generic version for Trospium Chloride was by Glenmark Pharmaceuticals Ltd and was approved on Aug 13, 2010. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Jun 18, 2024.

Given below is the list of companies who have filed for Trospium Chloride generic, along with the locations of their manufacturing plants worldwide.